Cardiac Patients for Non-Cardiac Surgery: Anesthetic Management in Patients with Permanent Pacemaker by Oktavia, Eva & Oktavia, Eva
Editorial
Indonesian J Cardiol ● Vol. 41, Issue 1 ● Jan - March 202032
Indonesian Journal of Cardiology
 pISSN: 0126-3773 / eISSN: 2620-4762
Cardiac Patients for Non-Cardiac Surgery: Anesthetic 
Management in Patients with Permanent Pacemaker
Eva Oktavia
Abstract
Permanent pacemakers (PPM) are often used in patients with electrophysiology 
disorders. After their device implantation, these patients can undergo cardiac or 
non-cardiac surgery with general or regional anesthesia. As an anesthesiologist, 
understanding patients’ condition, pacemaker care, and safe anesthetic tech-
nique are critical to providing safe patient management. This literature review 
discussed a systematic approach for managing these patients.
We discussed various approaches and guidelines on anesthesia management of 
patients with PPM. Particularly, in this review, the American Society of Anesthe-
siology (ASA) standard was used. Additionally, choices of safe anesthesia tech-
niques should base on patients’ clinical condition, the surgical procedure, the 
duration of surgery, and the convenience of the surgeon.
Overall, patients with PPM require special attention to perioperative manage-
ment. The anticipation of the patient’s condition and the performance of PPM 
must always be considered to provide safe anesthesia practice.
(Indonesian J Cardiol. 2020;41:32-39)
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Patients with cardiac diseases are commonly found in anesthesia practice and give a considerable challenge to the anesthesiologists due to higher risks of perioperative morbidity and mortality. 
The current development and improvement of diagnostic 
technology enable early detection of electrophysiology 
disorders in many patients, especially the elderly. In 
terms of treatment, pacemakers are one of the most 
reliable documented treatments for both conduction 
and arrhythmia problems in such patients.1-6 
More than 3 million patients in the United 
States have pacemakers and these numbers have been 
increasing worldwide. In a recent survey from India, 
Shenthar et al. reported that 37,000 cardiac device 
implantations take place annually in India and about 
80% of these procedures consisted of bradycardia-
Indonesian J Cardiol 2020:41:32-39
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related permanent pacemaker (PPM) insertions. In 
Indonesia, the prevalence of bradyarrhythmias with 
PPM implantations is still unknown but it is undeniably 
increasing each year.1-5, 7 
As the number of PPM implantation worldwide 
is getting higher, the number of patients with PPM 
present for cardiac or non-cardiac surgery also increase. 
Hence, it is reasonable to expect anesthesiologists to 
encounter these kinds of patients in their daily practice 
and to understand the characteristics, problems, and the 
interaction among PPM device, anesthesia procedure, 
and anesthesia agents to safely provide anesthesia for 
patients with any of these implanted devices.1-5, 7, 8 
Understanding Permanent Pacemaker (PPM)
PPM consists of a generator (such as electric circuit 
and battery) and electrodes accompanied by leads (this 
will be subsequently referred to as leads), designed for 
pacing, sensing or both in order to prevent bradycardia. 
The lithium-iodide batteries are the energy source of 
pacemaker generator, which can last for 5-10 years and 
commonly implanted in the infraclavicular region of 
the anterior chest wall. PPM usually has one or more 
leads, such as atrial lead and/or ventricular lead, which 
are implanted using either percutaneous or transvenous 
method. Leads perform to detect and deliver stimulus 
to the designated heart chamber based on the device 
settings. They consist of unipolar (single) and bipolar 
(dual) leads. For the clinical use, generators with bipolar 
leads can be programmed into the unipolar mode.2, 4, 8-14 
In electrocardiography (ECG), unipolar leads will 
give the image of spike pacing, because it works to 
deliver a big electricity vector caused by a large physical 
gap between leads and generator. Therefore, unipolar 
leads tend to be easily interrupted because it can pick 
up extracardiac stimuli and myopotentials, for instance, 
from thorax joint contraction. Meanwhile, bipolar 
leads consist of two separate leads and both of them 
are located in the triggered heart chamber. Both leads 
are side by side and can result in uninterrupted bipolar 
trigger. Hence, it is rare to find spike pacing in ECG.4, 
9-11, 13 
Single-chamber pacing has a trigger generator with 
a lead in the right ventricle. Dual-chamber pacing has 
a trigger generator with two leads; one is placed on the 
right atrium while the other one on the right ventricle. 
There is also biventricular pacing which has a trigger 
generator with three leads; each of them is put on the 
right atrium, right ventricle, and coronary sinus in 
order to make a possible trigger on the left ventricle. 
Meanwhile, epicardial pacing consists of a trigger 
generator with leads which is put directly on the surface 
of the heart (right atrium or right ventricle) through 
surgery procedure, but this technique is outdated and 
replaced with a transvenous method. Now epicardial 
pacing is only used for temporary pacing after open-
heart surgery and has to be immediately replaced with 
PPM. In addition, leadless system pacing is a pacing 
device that consists of a generator and leads put together 
in one unit and is put on the right ventricle using the 
transvenous method.2 
Pacemaker Nomenclature
Understanding the classification of a cardiac 
pacemaker can give comprehension regarding the 
chamber being paced, the chamber being sensed, and 
the type of response to sensing (as seen in table 1). 
The five-position system of pacemaker is commonly 
used based on North American Society of Pacing and 
Electrophysiology/British Pacing and Electrophysiology 
Group (NASPE/BPEG) (2002). It is also known as 
generic codes of the pacemaker. Basic functions of 
anti-bradycardia are indicated in the first three letters, 
while the fourth letter explains the program feature 
Table 1. Generic codes of pacemaker 4, 9-16 
Position I II III IV V
Category Pacing Sensing Response Programming Multisite pacing
Letter O O O O O
A A T R A
V V I V
D (A+V) D (A+V) D (T+I) D (A+V)
A: Atrium, D: Dual, I: Inhibited, O: None, R: Rate modulation, S: Shock, T: Triggered, V: Ventricle.
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which includes cardiac frequency modulation, and the 
fifth letter describes multisite pacing function. In daily 
practice, most clinicians use only three-letter model for 
communication.2, 4, 8-15 
A few years ago, pacemaker used fixed rate, but 
soon it was replaced with a system that could detect 
spontaneous depolarization of ventricle and prevent 
unnecessary ventricle stimulus delivery (single chamber 
atrial/ventricular pacing).4, 10, 13, 15
The modern pacemakers can be programmed into 
various modes. The most common PPM modes are 
AAI, VVI, and DDD (dual chamber pacing). Pacing 
with DDD mode can minimize the incidence of 
pacemaker syndrome and gives more hemodynamic 
efficiency compared to single-chamber pacing mode. 
However, the more physiologic PPM mode is DDDR 
(rate adaptive), because heart activity can be adjusted 
with patients’ metabolic needs during physical, mental, 
or emotional activity. Several modern PPMs can also 
automatically shift to other pacing modes based on 
patients’ conditions.4, 10, 11, 13,15 
Anesthesia Management
Anesthesia management for patients with PPM can 
be complicated. Several perioperative guides have been 
developed for managing these patients. In this review, 
the American Society of Anesthesiology (ASA) standard 
was chosen as a framework for clinical approach in 
Table 2. Perioperative approach for patients with PPM4, 10, 13, 16
Perioperative period Patients with PPM approach
Preoperative Indications of implantation
Type and product
Current function mode setting
Can it function well?
How far patients depend on the pacemaker?
Is it necessary to have reprogramming before surgery?




Postoperative Soon after the surgery
Evaluation
ASA: American Society of Anesthesiologist, AV: atrioventricular, ECG: electrocardiography, EMI: electromagnetic interference, NIBP: 
noninvasive blood pressure, PPM: Permanent pacemaker
perioperative management patients with PPM (as seen 
in table 2).
1. Preoperative preparation
Evaluation and optimization of co-existing diseases 
preoperatively are necessary. One of the most common 
co-existing diseases in patients with electrophysiology 
disorders is heart failure, which is related to the 
dysfunction of SA and/or AV node to trigger the systolic 
contraction of the right ventricle and left atrium.4, 9-13 
A pre-anesthetic assessment of current PPM type 
and function is necessary. This can be done by tracking 
down patients’ medical history, medical records, PPM 
information card, and cardiologist contact number as 
well as PPM producer. It is also recommended that the 
PPM function has already been examined at least once 
in the past twelve months prior to surgery.2-5, 8-14, 16 
Another method to determine which PPM type is 
used by the patients prior to anesthesia is by conducting 
several routine diagnostic examinations. The necessary 
minimum examinations are as follows:
● 12 leads ECG: This aims to determine patients’ 
baseline heart rhythm, pacemaker activity, and 
cardiac pacing.
● Chest x-ray: This is performed to check the PPM 
position, type, and integration (leads and generator) 
as well as signs of heart failure.
● Electrolytes: A normal limit should be ensured 
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because changes in K+ plasma concentration can 
cause the decrease of heart response towards PPM 
or defibrillator.
The other diagnostic examinations can be done 
based on clinical indication.2, 4, 8-10, 12-14, 16 
The next step is to determine patients’ dependency 
on his/her pacemaker. If it is not possible to confirm 
with the respective cardiologists or PPM producer, 
then patients’ medical history and preoperative ECG 
examination can help anesthesiologists determine 
the perioperative status of patients.  History of 
bradyarrhythmia or syncope which underlies the PPM 
insertion, or history of AV node ablation can provide 
information about patients’ dependency on his/her 
pacemaker. If a spike wave exists at every beginning of 
P wave or QRS complex in ECG examination, it can 
be concluded that the patients’ dependency on his/her 
pacemaker is high.2, 4, 5, 13, 16 
After the evaluation of patients’ dependency on 
his/her PPM, a determination of the implanted PPM 
reprogramming/resetting should be considered. This 
is done based on patients’ baseline heart rhythm, his/
her hemodynamic status, the upcoming surgical 
procedure, and the possibility of intraoperative EMI 
exposure. Patients who are less dependent on his/her 
PPM do not need to have his/her PPM reprogrammed. 
Anesthesiologists need to pay attention to fasciculation, 
shivering, and hyperventilation during the induction or 
emergence period because they can disturb the function 
of cardiac frequency modulation in PPM, especially 
the rate-adaptive type. Stimulation in this respective 
type of PPM which is due to the aforementioned 
clinical conditions will be interpreted by PPM as an 
increase in metabolic activity and can trigger pacemaker 
tachycardia.2, 4, 5, 9-14, 16 
2. Intraoperative
It is necessary to ensure the possibility of EMI 
exposure during surgery. Electromagnetic exposure 
towards PPM can change the variety of the pacing 
setting, depending on the implanted PPM and the 
specific device producer. The possible effects can 
include setting alteration, reprogramming, and device 
deactivation. Therefore, before the surgery, it is crucial 
to recognize the initial effect which is possible to occur if 
the applied PPM receives electromagnetic exposure, and 
the most credible method is by contacting the device 
producer directly.2, 4, 5, 9-13 
EMI source is derived from electrocautery or 
diathermy in the operating room. Electrocautery can 
cause inhibition and/or triggering of asynchronous of 
an electrical impulse towards cardiac performance. Most 
surgeries use unipolar electrocautery, but for the surgery 
of patients with PPM, it is highly recommended to 
use bipolar electrocautery. Studies report that unipolar 
electrocautery is far more susceptible to cause PPM 
interference compared to bipolar coagulation cautery. 
In bipolar cautery, the electrical current flow is localized 
between the two poles of the instrument. Meanwhile, 
in unipolar electrocautery, the electrical current flow is 
not restricted. Instead, it spreads throughout the body 
which will increase the risk of electrocautery current 
flow to intersect the pacemaker device and to trigger 
device malfunction. Basically, the EMI generated by 
electrocautery is related to distance and orientation 
of the current to the patient’s PPM device. Therefore, 
the electrocautery pad must always be located as far as 
possible from the implanted pacing generator position. 
During the procedure, anesthesiologists must always 
be cautious about the risk of intraoperative tachycardia 
despite the usage of bipolar electrocautery. A defibrillator 
should be prepared and be available in the operating 
room prior to surgery. In case malignant tachycardia 
occurs, defibrillation can be done using the temporary 
defibrillator.2, 4, 8-10, 13, 14, 16 
The usage of shortwave diathermy near the PPM 
generator can cause an increase in the temperature of 
the surrounding tissues. Hence, overheating in the 
generator can happen, which results in the damage 
of leads insulator. Therefore, the use of intraoperative 
diathermy should be kept as minimum as, as brief as, 
and as low as possible. In case of the occurrence of a 
hemodynamic problem in patients, diathermy usage 
should be stopped to reduce interruption towards 
hemodynamic monitoring. In addition, the other 
sources of EMI that can be found in the operating 
room are internal and external temporary pacing, 
transcutaneous nerve stimulator device, and evoked 
potential monitoring device. Those devices can compete 
with PPM in performing its function.2, 4, 5, 8-10, 13, 14, 16 
Another thing that should be taken into 
consideration is the usage of a harmonic scalpel. Even 
though it does not trigger EMI, it can cut PPM leads. 
In addition, the harmonic scalpel uses ultrasonic waves, 
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causing mechanical dysfunction of PPM, which will 
trigger ventricular extrasystole (VES). Therefore, it is 
recommended to put some distance between this device 
and leads generator, which is at least 15 inches, and to 
increase the amount of ultrasonic wave gradually based 
on the expected outcome.4, 8-10, 13, 14, 16-21 
In terms of anesthesia, the induction techniques and 
anesthetic maintenance depend on the patients’ clinical 
condition. Generally, anesthetic agents do not affect the 
function of PPM, but it will affect patients’ physiologic 
condition. Therefore, the anesthesia technique need to 
be adjusted based on the patients’ clinical condition.2, 4, 
9, 12-14, 22 
In general anesthesia, narcotics and inhalational 
agents can be used safely for patients with PPM. 
However, for patients with bradycardia, high dosage 
of fentanyl and dexmedetomidine must be avoided, 
because it will increase cardiac dependency towards 
PPM by altering PPM electrical trigger and stimulation 
threshold. The usage of N2O intraoperatively can also 
cause PPM malfunction due to its infiltration in the 
possible space around PPM implantation in the pectoral 
area. This infiltration will cause the accidental removal 
of anode lead from pacing generator.2, 4, 9, 12-14, 22
The other agents which should also be avoided 
for patients with PPM are succinylcholine, etomidate, 
and ketamine, because they can trigger fasciculation or 
myoclonus which can interrupt the function of PPM. 
Succinylcholine can still be given for rapid sequence 
induction (RSI) on condition that premedication of non-
depolarized muscle relaxation must be performed first 
in order to achieve de-fasciculation. This complication 
can be averted by doing PPM reprogramming into 
asynchronous mode prior to induction. Besides those 
agents, the usage of methadone, haloperidol, ondansetron 
as well as high dosage of anesthetic inhalation should 
be avoided towards patients with prolonged QT 
interval syndrome, because it can increase the risk of 
polymorphic ventricular tachycardia.2, 4, 9, 12-14, 22 
Neuraxial anesthesia is the first choice for patients with 
PPM, especially for ones with co-existing cardiovascular 
diseases, because it has less effects on their physiology 
and enables fast recovery. Nevertheless, it is important 
to pay attention to the patients’ clinical condition, the 
estimated duration of surgery, the convenience of the 
surgeons. Spinal anesthesia can be used by giving a low 
dosage of hyperbaric local anesthesia so that the side 
effect of hypotension can be reduced. The low dosage of 
intrathecal opioid as adjuvant should also be considered 
to increase the effectiveness of analgesia intraoperatively 
and postoperatively.18-20 
Another advantage of neuraxial anesthesia technique 
is that it needs a smaller number of anesthetic agents, 
thus can reduce the effect on cardiac depression and 
the other side effects. The suppression of intraoperative 
stress hormone release is also better than one in 
general anesthesia, which results in better myocardial 
oxygenation. Minimal postoperative pain related to the 
usage of long-acting opioid as an adjuvant leads to faster 
recovery.18-20 
Anesthesiologists need to pay attention to the 
possibility of device migration related to patient 
positioning and intraoperative positive pressure 
ventilation. Therefore, the function and the integration 
of PPM, must always be evaluated before and after 
performing those procedures.2, 4, 9, 12-14, 22 
Regarding intraoperative monitoring, ASA 
standardized monitoring devices must always be 
available and applied before induction. This includes 
ECG monitor, pulse oximetry (with plethysmograph), 
and noninvasive blood pressure (NIBP). The usage 
of invasive monitoring devices (intra-arterial blood 
pressure and pulmonary pressure monitoring, body 
core temperature monitoring) perioperatively can be 
adjusted based on the indication of surgical procedure 
as well the patients’ clinical condition.4, 5, 9, 11-14, 22 
It is crucial be vigilant the ECG monitor during 
the surgery because patients with PPM are at risk of 
undergoing dysrhythmia and being exposed to EMI 
anytime. PPM should be continuously displayed in 
the ECG monitor by decreasing or adjusting filter 
sensitivity in the monitor device. Meanwhile, arterial 
pressure monitoring parameters (such as pulsation 
palpation, heart rate auscultation, intra-arterial pressure 
display or ultrasound peripheral pulse monitoring) and 
pulse oximeter with plethysmography can be applied to 
confirm the heart rate and the hemodynamic stability.2, 
4, 5, 9, 11-16, 22 
All in all, good monitoring, emergency medicine, 
temporary pacemaker, and external defibrillator must 
always be available in the operating room. External 
defibrillator pads must also be applied before anesthetic 
induction, which is on the heart apex (left side of 
anteroposterior breast region) and on axillae, or under 
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right clavicle. The distance between defibrillator pads 
and implanted PPM generator is at least 10 cm to avoid 
the possibility of damage in the device as well as device 
reprogramming. Isoprenaline infusion can be provided 
in case the increase or improvement of heart rhythm or 
frequency is needed.2, 4, 5, 9, 10, 12, 13, 15, 16, 22 
Perioperative PPM failure can be affected by three 
factors: (1) the failure of pacing generator (this rarely 
happens), (2) the failure of leads (this also rarely 
happens. If it does, this is due to the dislocation when 
positioning patients), and (3) the failure in receiving 
heart pacing or the increase of pacing threshold (this is 
more common to happen due to ischemia or myocardial 
infarction, acid-base and electrolyte imbalances, or high 
concentration of antiarrhythmic drugs in the circulating 
blood). If this failure affects the stability of patients’ 
hemodynamic, the following steps can be performed.
1. Give magnetic exposure to PPM. This can be 
done if it has been previously diagnosed that PPM 
performance is converted into an asynchronous 
mode when exposed to magnets. This action will 
increase the device sensitivity in receiving the trigger 
of heart pacing.
2. Use a temporary pacemaker. This can be done via 
transcutaneous, transvenous, and transesophageal.
3. Give pharmacologic therapy to increase heart 
frequency, the limit of cardiac depolarization, or 
even both. The agents used are epinephrine (0.5-
1 μg/minute), dopamine (5-20 μg/kg/minute), 
isoproterenol (0.5-10 μg/kg/minute), or atropine.
4. Find and treat the cause of myocardial ischemia. 
Ischemia increases energy consumption in order to 
perform ventricular contraction.
5. Find and treat the possibility of electrolyte 
imbalance, acid-base disturbance, or side effects of 
antiarrhythmic drugs.
6. Consider putting an epicardial pacing device 
surgically if the aforementioned steps do not give a 
positive outcome.4, 11, 13, 14, 22 
It is important to remember that tachycardia will 
not be found intraoperatively during hemodynamic 
monitoring towards patients with PPM especially the 
ones with a high dependency on his/her pacing device 
(programmed with fixed-rate), even in hypovolemic 
condition. Therefore, strict monitoring of intraoperative 
bleeding and fluid replacement is crucial.2 
During an intraoperative emergency such as 
arrhythmia or bradycardia, any magnets should be kept 
away prior to defibrillation, so that the tachyarrhythmia 
function of PPM can be reactivated. All possible sources 
of EMI exposure should be stopped, so the actual heart 
rhythm and rate can be achieved and diagnosed. If the 
failure of the PPM function is confirmed, patients will 
need defibrillation or cardioversion to return their heart 
rhythm to their initial rhythm. During this period, 
ECG monitoring must be done continuously in order 
to determine the ventricular frequency and the heart 
rhythm, because there is a possibility that the recorded 
ventricular rhythm is lower than the PPM setting. If 
that happens, postoperative device reprogramming is 
needed. However, it is rare to have the device ended in 
a complete failure despite EMI exposure. The device 
problems usually consist of inaccurate impulse delivery 
or excessive increase in pacing frequency (180-200 
times/minute).2 
3. Postoperative
Patients must always be monitored strictly during 
the postoperative period and a pacing device with 
external defibrillator function must always be available 
until it can be confirmed that PPM is functioning 
normally. Ideally, the patients’ PPM must be under 
reexamination during this period to check whether its 
running function or mode is in good condition before 
sending the patients back to the ward. This is very 
important especially if problems are encountered during 
the intraoperative period.2-4, 9-16 
PPM and Central Venous Catheter (CVC) 
Insertion
In several non-cardiac operations, such as 
neurosurgery, spine surgery, or laparotomy, central venous 
access needs to be established prior to surgery. This will 
also be useful for postoperative access in the intensive 
care unit. Performing CVC insertion in patients with 
PPM can bring a dilemma to anesthesiologists regarding 
which insertion site is safer, which safe technique should 
be used, and what possible complications may occur in 
such patients.23-25
Venous complications after placement of PPM 
occur in approximately 30-45% of cases such as 
stenosis, hematoma, thrombophlebitis, and thrombosis, 
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with or without symptoms. The incidence of bacterial 
infection after transvenous leads placement reported 
approximately 0.2-4%, meanwhile catheter-related 
bacteremia after CVC insertion has been estimated 1.6-
5.5 episodes per thousand catheter days. Therefore, it is 
reasonable to consider that placing an additional CVC 
within the same path of co-existing transvenous leads 
may be associated with even greater complications. So 
far there have not been published guidelines or literature 
regarding the placement of CVC in patients with 
implanted pacemaker.23-25 
Internal jugular and subclavian vein are the most 
preferable site for CVC insertion. While, in patients 
with PPM, they have pre-existing implanted cardiac 
pacemaker in the chest region with pacemaker leads 
lies in the adjacent venous system. Needle puncture 
attempt during CVC insertion on the ipsilateral site 
of PPM should consider the risk of direct contact of 
CVC guidewire with pacemaker leads intravenously. 
This condition can trigger leads malfunctioning by 
triggering inappropriate shock, displacement, or even 
damaging the implantable cardiac device. Other possible 
complications are dislodgement of thrombus and 
disseminated bacterial infection surrounding pacemaker 
leads, and the possibility of malposition or displacement 
of central catheter.23, 24
CVC insertion on the contralateral side of PPM is 
preferred if no contraindication, such as the presence of 
tumor or lesions, exists. If ipsilateral side is preferred, it 
is recommended to consider either the internal jugular 
or femoral vein as the sites of insertion.23
Conclusion
Patients with PPM and cardiovascular diseases 
need special attention in perioperative anesthesia 
management, particularly in terms of patients’ 
clinical condition and PPM performance. Emergency 
equipment such as a temporary pacing device must 
always be available in operating and recovery room to 
treat the possible complication during the perioperative 
period. It is highly recommended to use intraoperative 
bipolar electrocautery in the surgery of patients with 
PPM to avoid PPM interference during surgeries. PPM 
reevaluation after surgery must be done to ensure that 
the device works according to the suitable mode and 
functions properly before patients are being transferred 
to the ward. When CVC insertion is required, it 
is recommended to perform the procedure on the 
contralateral side of the implanted pacemaker to avoid 
unwanted complications.
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